Stock AUPH AURINIA PHARMACEUTICALS INC.
Add to a list
To use this feature you must be a member
Log inSign up

Revisions Aurinia Pharmaceuticals Inc.

Equities

AUPH

CA05156V1022

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-20 pm EDT 		5-day change 1st Jan Change
5.78 USD +0.35% Intraday chart for Aurinia Pharmaceuticals Inc. +15.14% -35.71%
May. 14 Aurinia Pharmaceuticals Inc. Presented Results from the Analysis Showing Lupkynis A Cost-Effective Treatment for Lupus Nephritis Presented At National Kidney Foundation's Spring Clinical Meeting 2024 CI
May. 07 Lucien Selce Urges Aurinia Pharmaceuticals Board to Take Action to Enhance Shareholder Value CI

Turnover - Change in analysts' estimates

Earnings Per Share (EPS) - Change in analysts' estimates

EBIT - Change in analysts' estimates

Cash or Net Debt - Change in analysts' estimates

Turnover

Earnings Per Share (EPS)

EBIT

Cash or Net Debt

  1. Stock Market
  2. Equities
  3. AUPH Stock
  4. Revisions Aurinia Pharmaceuticals Inc.
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW